Prostate cancer in cats: treatment, prognosis and clinical trials
Cats · USA & Canada
Understanding prostate cancer
Feline prostate cancer is exceptionally rare. It can interfere with urination or defecation and may spread to lymph nodes, lungs or bone. Because published feline experience is limited, the most useful questions are what the tumor is obstructing, how far it has spread and what local control is realistically possible.
What does the prognosis look like?
There is not enough feline evidence for a reliable survival estimate. The immediate outlook is most serious when the tumor interferes with urination or defecation; inability to pass urine is an emergency. If your cat is stable, imaging and staging can show whether local treatment is possible and whether cancer is present elsewhere. Canine prostate-cancer statistics are not a dependable substitute.
What matters next
The immediate question is whether the mass is interfering with urination or defecation; inability to pass urine is an emergency. Once your cat is stable, define the tumor’s extent and whether it has spread before deciding whether surgery, a procedure to maintain urine flow, medical treatment or supportive care is realistic.
Where are you now?
Urination is difficult or impossible
Inability to pass urine is an emergency. Stabilization and restoration of urine flow come before a long-term cancer plan; ask whether catheterization, stenting, or another diversion procedure is feasible.
Surgery is being considered or already done
Ask exactly what procedure is possible and what urinary complications are expected. Keep the full histopathology because published feline experience includes different carcinoma subtypes.
Metastatic disease is present
Discuss symptom control and systemic options with the understanding that feline evidence is extremely sparse. Individual case reports should not be treated as a standard expected outcome.
If you are waiting for oncology
Feline prostate cancer is exceptionally rare, so obstruction and diagnosis deserve priority over importing a standard canine pathway. Difficulty urinating or defecating may require intervention before oncology treatment.
Questions to ask your oncologist
- How secure is the diagnosis and what structures are obstructed or invaded?
- Is there evidence of nodal, lung or bone spread?
- Which treatment options are supported by feline experience versus extrapolated from dogs?
How the diagnosis may appear in the record
Feline prostate carcinoma is exceptionally rare, so confirmation of tumor origin is important. The record should distinguish prostatic carcinoma from urothelial disease involving the prostate when possible and document effects on the urethra, bladder, bowel, nodes, lungs, and bone.
Changes to watch for at home
Watch for repeated litter-box visits, straining to urinate or defecate, blood in urine, constipation, pelvic pain, hiding, or reduced appetite. Little or no urine, vomiting with urinary difficulty, severe pain, or collapse is an emergency.
How it is usually treated
There is no established feline standard because this cancer is exceptionally rare. Treatment is individualized and may include surgery in selected anatomy, radiation or systemic treatment, procedures to maintain urine flow and supportive care.
What can affect treatment choices
Obstruction, local invasion, metastasis, kidney function and confidence in the diagnosis matter most. Because feline data are sparse, every treatment choice is more individualized than in dogs.
Tests that may matter
Ultrasound or CT helps define the prostate, urethra, bladder and regional lymph nodes. Chest imaging is reasonable because metastasis can occur. Cytology or histopathology is used to confirm tumor type when a sample can be obtained safely and when the result will alter management.